(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 12.11%9.17B | ---- | -2.35%8.18B | ---- | -6.10%8.38B | ---- | -14.21%8.93B | ---- | -15.69%10.4B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -58.04%-323.2M | ---- | -19.59%-204.5M | ---- | 8.65%-171M | ---- | 14.75%-187.2M | ---- | 26.63%-219.6M |
Interest expense - adjustment | ---- | 24.71%2.21B | ---- | 26.10%1.78B | ---- | 11.00%1.41B | ---- | 3.10%1.27B | ---- | 4.57%1.23B |
Dividend (income)- adjustment | ---- | -3.46%-173.5M | ---- | -9.39%-167.7M | ---- | -6.53%-153.3M | ---- | -36.53%-143.9M | ---- | 16.22%-105.4M |
Attributable subsidiary (profit) loss | ---- | -174.38%-2.93B | ---- | 57.88%-1.07B | ---- | -11.26%-2.53B | ---- | 11.15%-2.28B | ---- | 49.89%-2.56B |
Impairment and provisions: | ---- | 949.47%3.29B | ---- | -80.02%313.9M | ---- | 221.15%1.57B | ---- | -60.50%489.3M | ---- | 421.52%1.24B |
-Impairment of trade receivables (reversal) | ---- | -23.41%56.6M | ---- | 86.15%73.9M | ---- | -6.59%39.7M | ---- | -20.86%42.5M | ---- | 43.20%53.7M |
-Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --333M |
-Other impairments and provisions | ---- | 1,249.04%3.24B | ---- | -84.33%240M | ---- | 242.82%1.53B | ---- | -47.55%446.8M | ---- | 325.95%851.9M |
Revaluation surplus: | ---- | 83.17%-83.1M | ---- | -227.40%-493.8M | ---- | 12,820.00%387.6M | ---- | 100.16%3M | ---- | -1,806.41%-1.87B |
-Fair value of investment properties (increase) | ---- | 96.83%-4.6M | ---- | -559.09%-145M | ---- | -833.33%-22M | ---- | 118.75%3M | ---- | -28.00%-16M |
-Derivative financial instruments fair value (increase) | ---- | 80.88%-101.6M | ---- | -248.22%-531.5M | ---- | --358.6M | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | -87.36%23.1M | ---- | 258.24%182.7M | ---- | --51M | ---- | ---- | ---- | -2,065.50%-1.86B |
Asset sale loss (gain): | ---- | -2,281.07%-5.36B | ---- | 3,332.89%245.7M | ---- | -110.27%-7.6M | ---- | 187.94%74M | ---- | 161.93%25.7M |
-Loss (gain) from sale of subsidiary company | ---- | ---5.41B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -67.13%69.3M | ---- | 1,045.65%210.8M | ---- | -74.66%18.4M | ---- | 181.40%72.6M | ---- | 2,250.00%25.8M |
-Loss (gain) from selling other assets | ---- | -160.46%-21.1M | ---- | 234.23%34.9M | ---- | -1,957.14%-26M | ---- | 1,500.00%1.4M | ---- | 99.75%-100K |
Depreciation and amortization: | ---- | 0.68%3.55B | ---- | 7.20%3.53B | ---- | 11.83%3.29B | ---- | 6.79%2.94B | ---- | 8.53%2.75B |
-Depreciation | ---- | 0.68%3.55B | ---- | 7.20%3.53B | ---- | 11.83%3.29B | ---- | 6.79%2.94B | ---- | 8.53%2.75B |
Exchange Loss (gain) | ---- | -82.60%15.9M | ---- | 211.87%91.4M | ---- | 35.72%-81.7M | ---- | -182.44%-127.1M | ---- | -116.02%-45M |
Special items | ---- | 155.20%701.2M | ---- | 41.36%-1.27B | ---- | -72.22%-2.17B | ---- | -35.22%-1.26B | ---- | 39.93%-930.2M |
Operating profit before the change of operating capital | ---- | -7.76%10.08B | ---- | 10.16%10.93B | ---- | 2.22%9.92B | ---- | -2.09%9.71B | ---- | 6.11%9.92B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 141.44%166.3M | ---- | -3.99%-401.3M | ---- | -78.24%-385.9M | ---- | -333.30%-216.5M | ---- | 107.14%92.8M |
Accounts receivable (increase)decrease | ---- | 114.73%317.2M | ---- | -1,231.60%-2.15B | ---- | 79.36%-161.7M | ---- | 17.85%-783.5M | ---- | -53.35%-953.7M |
Accounts payable increase (decrease) | ---- | -74.30%315.5M | ---- | 24.55%1.23B | ---- | -10.57%985.5M | ---- | 38.11%1.1B | ---- | 29.07%797.9M |
Advance payment increase (decrease) | ---- | 120.81%43.5M | ---- | -78.66%19.7M | ---- | -6.48%92.3M | ---- | 451.40%98.7M | ---- | -55.14%17.9M |
Cash from business operations | ---- | 13.52%10.93B | ---- | -7.93%9.63B | ---- | 5.50%10.45B | ---- | 0.39%9.91B | ---- | 4.72%9.87B |
Special items of business | -9.64%4.71B | -73.44%5.1M | 17.40%5.22B | 27.15%19.2M | -15.78%4.44B | 2,416.67%15.1M | 21.55%5.28B | -98.55%600K | -10.99%4.34B | 232.00%41.5M |
Net cash from operations | -9.64%4.71B | 13.34%10.93B | 17.40%5.22B | -7.88%9.64B | -15.78%4.44B | 5.64%10.47B | 21.55%5.28B | -0.02%9.91B | -10.99%4.34B | 5.02%9.91B |
Cash flow from investment activities | ||||||||||
Interest received - investment | -26.14%133.1M | 53.04%325.2M | 87.32%180.2M | 23.76%212.5M | 12.25%96.2M | -6.38%171.7M | -13.43%85.7M | -21.52%183.4M | -11.69%99M | -24.71%233.7M |
Dividend received - investment | 9.67%1.33B | 16.18%1.88B | 101.63%1.21B | -6.54%1.62B | -22.12%600.8M | -12.33%1.73B | 70.85%771.4M | -4.09%1.97B | -29.03%451.5M | 2.08%2.06B |
Loan receivable (increase) decrease | ---- | 213.42%228.8M | ---- | -60.77%73M | ---- | -49.13%186.1M | ---- | 309.15%365.8M | ---- | -36.21%-174.9M |
Decrease in deposits (increase) | -679.55%-25.5M | -708.87%-123.6M | 109.52%4.4M | -79.18%20.3M | -96.82%2.1M | 1,207.95%97.5M | -23.70%66M | -105.03%-8.8M | -10.08%86.5M | -89.85%175.1M |
Sale of fixed assets | ---- | 20.79%73.8M | ---- | -34.44%61.1M | ---- | 185.89%93.2M | ---- | -57.27%32.6M | ---- | -43.98%76.3M |
Purchase of fixed assets | 12.28%-3.15B | -8.22%-8.36B | -11.47%-3.6B | -6.20%-7.72B | 10.26%-3.23B | -0.77%-7.27B | -34.23%-3.59B | -6.91%-7.22B | 14.61%-2.68B | -2.81%-6.75B |
Purchase of intangible assets | 41.98%-14.1M | 88.86%-67.9M | -81.34%-24.3M | 46.44%-609.7M | 82.06%-13.4M | -1,372.70%-1.14B | -80.00%-74.7M | 74.37%-77.3M | 79.39%-41.5M | -68.49%-301.6M |
Sale of subsidiaries | 104.65%88.1M | --3.33B | ---1.89B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---97.2M | ---299.5M | ---- | ---- | ---- | ---- | ---5.23B | ---- | ---- | ---- |
Recovery of cash from investments | ---- | 83.96%137.6M | ---- | -72.53%74.8M | ---- | 82.38%272.3M | ---- | 195.06%149.3M | ---- | -93.70%50.6M |
Cash on investment | 94.72%-14.1M | 26.63%-519.9M | -100.98%-266.9M | 89.75%-708.6M | 74.82%-132.8M | -490.40%-6.92B | -56.99%-527.5M | -82.25%-1.17B | -179.77%-336M | 67.03%-642.7M |
Other items in the investment business | -141.69%-164.8M | 304.24%906.3M | 534.87%395.3M | 254.09%224.2M | -114.86%-90.9M | 33.50%-145.5M | 117.03%611.6M | -843.10%-218.8M | 345.90%281.8M | -182.93%-23.2M |
Net cash from investment operations | 51.86%-1.92B | 63.09%-2.5B | -44.31%-3.99B | 47.68%-6.76B | 64.99%-2.76B | -115.74%-12.92B | -269.46%-7.89B | -12.99%-5.99B | 21.67%-2.14B | -40.36%-5.3B |
Net cash before financing | 127.47%2.79B | 192.49%8.44B | -26.88%1.23B | 217.61%2.88B | 164.18%1.68B | -162.55%-2.45B | -218.73%-2.62B | -14.98%3.92B | 2.56%2.2B | -18.56%4.61B |
Cash flow from financing activities | ||||||||||
New borrowing | 5.43%2.54B | -2.10%30.47B | -28.65%2.41B | 13.82%31.12B | -60.91%3.38B | 35.21%27.34B | 177.45%8.65B | -8.13%20.22B | 214.12%3.12B | 7.24%22.01B |
Refund | ---- | -30.01%-33B | ---- | -50.58%-25.39B | ---- | -1.77%-16.86B | ---- | 14.79%-16.57B | ---- | 8.28%-19.44B |
Issuing shares | ---- | ---- | ---- | 44.44%3.39B | ---- | --2.35B | ---- | ---- | ---- | ---- |
Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.34B |
Interest paid - financing | -14.83%-1.21B | -20.21%-2.12B | -11.02%-1.05B | 0.44%-1.76B | 1.26%-945.8M | -18.08%-1.77B | -26.02%-957.9M | -1.37%-1.5B | -0.80%-760.1M | 7.54%-1.48B |
Dividends paid - financing | 0.00%-4.29B | -0.53%-7.19B | 0.00%-4.29B | -3.12%-7.16B | -5.00%-4.29B | -5.68%-6.94B | -5.00%-4.09B | -8.62%-6.57B | -10.00%-3.89B | -8.43%-6.04B |
Absorb investment income | ---- | -14.13%64.4M | ---- | -60.82%75M | ---- | 402.36%191.4M | ---- | -61.94%38.1M | ---- | -40.84%100.1M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.41B |
Other items of the financing business | ---- | -187.21%-173.8M | -105.82%-2.9M | -83.66%199.3M | 186.16%49.8M | 7,725.00%1.22B | -52.51%-57.8M | 90.60%-16M | ---37.9M | -46.68%-170.3M |
Net cash from financing operations | 7.03%-3.08B | -3,614.48%-12.45B | -76.17%-3.31B | -93.43%354.2M | -153.74%-1.88B | 219.35%5.4B | 312.88%3.49B | 13.30%-4.52B | 52.21%-1.64B | 33.06%-5.21B |
Effect of rate | 59.79%-163.5M | 53.55%-257.5M | -110.67%-406.6M | -447.59%-554.4M | -550.93%-193M | -22.57%159.5M | 165.85%42.8M | 515.32%206M | -1,610.53%-65M | 62.31%-49.6M |
Net Cash | 86.46%-281.5M | -223.87%-4.01B | -950.68%-2.08B | 10.06%3.24B | -122.58%-197.9M | 590.50%2.94B | 55.62%876.3M | 0.40%-599.9M | 143.82%563.1M | 71.67%-602.3M |
Begining period cash | -32.24%8.97B | 25.43%13.24B | 25.43%13.24B | 41.61%10.56B | 41.61%10.56B | -5.02%7.46B | -5.02%7.46B | -7.67%7.85B | -7.67%7.85B | -20.99%8.5B |
Cash at the end | -20.72%8.53B | -32.24%8.97B | 5.80%10.76B | 25.43%13.24B | 21.40%10.17B | 41.61%10.56B | 0.32%8.37B | -5.02%7.46B | 15.74%8.35B | -7.67%7.85B |
Cash balance analysis | ||||||||||
Cash and bank balance | -20.72%8.53B | ---- | 5.80%10.76B | ---- | 21.40%10.17B | ---- | --8.37B | ---- | ---- | ---- |
Cash and cash equivalent balance | -20.72%8.53B | -32.24%8.97B | 5.80%10.76B | 25.43%13.24B | 21.40%10.17B | 41.61%10.56B | 0.32%8.37B | -5.02%7.46B | 15.74%8.35B | -7.67%7.85B |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data